Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas System”
1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8945544
Immunogenic compositions comprising progastrin and uses thereof
granted -
US 8948863
Photokinetic ocular drug delivery methods and apparatus
granted -
US 8946194
One-step processing of hydrogels for mechanically robust and chemically desired features
granted -
US 8945868
Methods and compositions for modification of a HLA locus
granted -
US 8945587
Synthetic lipid biology for combinatorial engineering of endotoxin
granted -
US 8946409
Polycyclic β lactam derivatives for the treatment of cancer
granted -
US 8940394
Protein imprinting by means of alginate-based polymers
granted -
US 8940711
Micro-RNA family that modulates fibrosis and uses thereof
granted -
US 8940712
Micro-RNA family that modulates fibrosis and uses thereof
granted -
US 8940713
Micro-RNA family that modulates fibrosis and uses thereof
granted -
US 8927506
Acetates of 2-deoxy monosaccharides with anticancer activity
granted -
US 8920625
Electrochemical method of making porous particles using a constant current density
granted -
US 8916606
Therapeutic compositions and methods for targeted delivery of active agents
granted -
US 8916519
Influenza A virus vaccines and inhibitors
granted -
US 8916197
Bone marrow-directing drug delivery materials and their applications
granted -
US 8911752
Methods of making compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity
granted -
US 8901095
Selective inhibition of polyglutamine protein expression
granted -
US 8895717
Delivery of siRNA by neutral lipid compositions
granted -
US 8889743
Inhibition of filovirus entry into cells and uses thereof
granted -
US 8889623
Immunostimulatory nanoparticles and related compositions, methods and systems
granted -
US 8883154
Antibody-mediated modulation of allergy
granted -
US 8883729
Nanolipoprotein particles and related compositions, methods and systems
granted -
US 8883841
Oncogenic ras-specific cytotoxic compound and methods of use thereof
granted -
US 8883174
Compositions for stimulation of mammalian innate immune resistance to pathogens
granted